259 related articles for article (PubMed ID: 9294126)
1. The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice.
Daugherty A; Puré E; Delfel-Butteiger D; Chen S; Leferovich J; Roselaar SE; Rader DJ
J Clin Invest; 1997 Sep; 100(6):1575-80. PubMed ID: 9294126
[TBL] [Abstract][Full Text] [Related]
2. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
3. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice.
Zhou X; Paulsson G; Stemme S; Hansson GK
J Clin Invest; 1998 Apr; 101(8):1717-25. PubMed ID: 9541503
[TBL] [Abstract][Full Text] [Related]
4. Immunization of low-density lipoprotein receptor deficient (LDL-RD) mice with heat shock protein 65 (HSP-65) promotes early atherosclerosis.
Afek A; George J; Gilburd B; Rauova L; Goldberg I; Kopolovic J; Harats D; Shoenfeld Y
J Autoimmun; 2000 Mar; 14(2):115-21. PubMed ID: 10677242
[TBL] [Abstract][Full Text] [Related]
5. Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice.
Zhou X; Stemme S; Hansson GK
Am J Pathol; 1996 Aug; 149(2):359-66. PubMed ID: 8701976
[TBL] [Abstract][Full Text] [Related]
6. The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice.
Davenport P; Tipping PG
Am J Pathol; 2003 Sep; 163(3):1117-25. PubMed ID: 12937153
[TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin treatment reduces atherosclerosis in apo E knockout mice.
Nicoletti A; Kaveri S; Caligiuri G; Bariéty J; Hansson GK
J Clin Invest; 1998 Sep; 102(5):910-8. PubMed ID: 9727059
[TBL] [Abstract][Full Text] [Related]
8. Human apolipoprotein A-IV reduces secretion of proinflammatory cytokines and atherosclerotic effects of a chronic infection mimicked by lipopolysaccharide.
Recalde D; Ostos MA; Badell E; Garcia-Otin AL; Pidoux J; Castro G; Zakin MM; Scott-Algara D
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):756-61. PubMed ID: 14751811
[TBL] [Abstract][Full Text] [Related]
9. IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice.
Whitman SC; Ravisankar P; Daugherty A
J Interferon Cytokine Res; 2002 Jun; 22(6):661-70. PubMed ID: 12162876
[TBL] [Abstract][Full Text] [Related]
10. Genetic background selectively influences innominate artery atherosclerosis: immune system deficiency as a probe.
Reardon CA; Blachowicz L; Lukens J; Nissenbaum M; Getz GS
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1449-54. PubMed ID: 12791670
[TBL] [Abstract][Full Text] [Related]
11. Splenectomy increases atherosclerotic lesions in apolipoprotein E deficient mice.
Rezende AB; Neto NN; Fernandes LR; Ribeiro AC; Alvarez-Leite JI; Teixeira HC
J Surg Res; 2011 Dec; 171(2):e231-6. PubMed ID: 21962813
[TBL] [Abstract][Full Text] [Related]
12. Development of atherosclerosis in Balb/c apolipoprotein E-deficient mice.
Desai A; Zhao Y; Warren JS
Cardiovasc Pathol; 2008; 17(4):233-40. PubMed ID: 18402814
[TBL] [Abstract][Full Text] [Related]
13. Expression of interleukin-15 in mouse and human atherosclerotic lesions.
Wuttge DM; Eriksson P; Sirsjö A; Hansson GK; Stemme S
Am J Pathol; 2001 Aug; 159(2):417-23. PubMed ID: 11485899
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
[TBL] [Abstract][Full Text] [Related]
15. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
16. Lymphocytes are not required for the rapid onset of coronary heart disease in scavenger receptor class B type I/apolipoprotein E double knockout mice.
Karackattu SL; Picard MH; Krieger M
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):803-8. PubMed ID: 15692099
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin deficiency attenuates atherosclerosis in female apolipoprotein E-deficient mice.
Matsui Y; Rittling SR; Okamoto H; Inobe M; Jia N; Shimizu T; Akino M; Sugawara T; Morimoto J; Kimura C; Kon S; Denhardt D; Kitabatake A; Uede T
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1029-34. PubMed ID: 12730087
[TBL] [Abstract][Full Text] [Related]
18. Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice.
Mallat Z; Gojova A; Brun V; Esposito B; Fournier N; Cottrez F; Tedgui A; Groux H
Circulation; 2003 Sep; 108(10):1232-7. PubMed ID: 12912803
[TBL] [Abstract][Full Text] [Related]
19. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice.
Shi W; Wang X; Wong J; Hedrick CC; Wong H; Castellani LW; Lusis AJ
Biochem Biophys Res Commun; 2004 Apr; 317(1):223-9. PubMed ID: 15047172
[TBL] [Abstract][Full Text] [Related]
20. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
Lee TS; Shiao MS; Pan CC; Chau LY
Circulation; 1999 Mar; 99(9):1222-9. PubMed ID: 10069791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
